Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...

Press/Media: Press / Media

PeriodApr 24 2015

Media coverage

2

Media coverage

  • TitleMerck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...
    Media name/outletWorld News Report
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ...
    Media name/outletEIN News
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz